DURHAM, N.C., Jan. 16, 2025 (GLOBE NEWSWIRE) -- (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced that ...

Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programsDURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) ...

Plans to build a long-promised biological manufacturing facility in Manhattan have fizzled, though company leaders prefer not ...

In recent trading, Scorpius Holdings Inc (SCPX) stock price has shown some volatility, fluctuating -4.01% over the last five trades and -8.26% over the past 30 trades. This represents a notable shift ...

Scorpius announced its collaboration with KaloCyte. Under this initial project, Scorpius will utilize its scientific and technical expertise to ...

Aims to accelerate the lead candidate’s journey toward clinical success and expand its reach to patients who need it.

Scorpius Holdings (SCPX) announced that the company’s planned 1-for-20 reverse stock split of its common stock that was announced yesterday, ...

Scorpius Holdings, Inc. has announced a collaboration with KaloCyte to improve the manufacturing efficiency of KaloCyte's lead product, ErythroMer™, a bio-engineered artificial red blood cell ...

ThunderCats: Lost #2 introduces Scorpius, a formidable new foe for the ThunderCats. Bengali, Pumyra, and Lynx-O make a return ...

In recent trading, Scorpius Holdings Inc (SCPX) stock price has shown some volatility, fluctuating -2.63% over the last five trades and 22.11% over the past 30 trades. This represents a notable shift ...

Scorpius Holdings said it will sell 29.4 million shares of its common stock for 34 cents apiece, as it reiterated its going-concern warning. The contract development and manufacturing company said ...

Scorpius Holdings, Inc., a pharmaceutical company with a market capitalization of just $1.41 million, disclosed in a recent SEC filing that it is in urgent need of additional capital to continue ...